Home > Riviste > Acta Phlebologica > Fascicoli precedenti > Acta Phlebologica 2021 August;22(2) > Acta Phlebologica 2021 August;22(2):69-72

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

CASE REPORT   

Acta Phlebologica 2021 August;22(2):69-72

DOI: 10.23736/S1593-232X.21.00495-1

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Pulmonary embolic episode after hybrid treatment with endovascular laser ablation combined with polidocanol foam sclerotherapy

Juan CIFUENTES 1, Jorge H. ULLOA 2 , Valentin FIGUEROA 3, Jose ORDOÑEZ 1, Ana MONTENEGRO 4, Camilo BARRAGAN 5

1 Faculty of Medicine, Universidad de Los Andes, Bogotá, Colombia; 2 Department of Vascular Surgery, Faculty of Medicine, University Hospital of Fundación Santa Fe de Bogotá, Universidad de Los Andes, Bogotá, Colombia; 3 Faculty of Medicine, Universidad de Los Andes, Bogotá, Colombia; 4 Department of Vascular Medicine, Faculty of Medicine, University Hospital of Fundación Santa Fe de Bogotá, Universidad de Los Andes, Bogotá, Colombia; 5 Department of Interventional Radiology, University Hospital of Fundación Santa Fe de Bogotá, Bogotá, Colombia



Foam sclerotherapy and endovenous laser ablation are minimally-invasive techniques that have demonstrated safety and effectiveness for the treatment of chronic venous insufficiency. However, some extremely rare adverse events might take place. We report an uncommon case of a 38-year-old woman who developed pulmonary embolism after performing hybrid treatment that combines laser and foam sclerotherapy in the great saphenous vein. Three days after the intervention, the patient developed fever, dyspnea, malaise, inspirational chest pain, tachypnea and oxygen desaturation. A computed tomography angiography confirmed the suspected diagnosis of pulmonary embolism. A venous Duplex scan of the lower limbs showed no thrombi in the superficial nor the deep venous system, and no signs of deep venous thrombosis were found in the leg examination. A hypercoagulable disorders screening indicated a previously silent antiphospholipid syndrome. Although the prevalence of thromboembolic complications is low in both sclerotherapy and endovascular laser ablation, combination of both strategies might increase its incidence, even more in patients with unknown and uncontrolled hypercoagulable disorders.


KEY WORDS: Pulmonary embolism; Laser therapy; Sclerotherapy; Polidocanol

inizio pagina